Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.

Antonio Solana-AltabellaBlanca BoludaRebeca Rodríguez-VeigaIsabel CanoEvelyn Acuña-CruzAlbert BlancoJavier Marco-AyalaRosalía de la PuertaÁlvaro Díaz-GonzálezJosé L PiñanaJaime SanzAmparo SempereJosé CerveraEva BarragánClaudia SargasOctavio Ballesta-LópezJuan Eduardo Megías-VericatDavid Martínez-CuadrónMiguel Á SanzPau Montesinos

Published in: European journal of haematology (2021)

Data from this study suggest that there is a substantial healthcare resource utilization and cost burden on R/R FLT3mut AML patients in Spain receiving active treatments.

Keyphrases

acute myeloid leukemia
healthcare
allogeneic hematopoietic stem cell transplantation
end stage renal disease

ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors

tyrosine kinase
patient reported outcomes
electronic health record
big data

risk factors
diffuse large b cell lymphoma
hodgkin lymphoma
data analysis